Skip to main content
PACIFIC EDGE LIMITED logo

PACIFIC EDGE LIMITED — Investor Relations & Filings

Ticker · PEB ISIN · NZPEBE0002S1 LEI · 9845007EDCF068FFEA12 ASX Professional, scientific and technical activities
Open in API
Filings indexed 747 across all filing types
Latest filing 2025-08-12 Share Issue/Capital Cha…
Country NZ New Zealand
Listing ASX PEB

About PACIFIC EDGE LIMITED

https://www.pacificedgedx.com/

Pacific Edge Limited is a cancer diagnostics company specializing in the development and commercialization of non-invasive molecular diagnostic tests. The company's primary product suite, Cxbladder, utilizes advanced mRNA biomarker technology to detect and monitor bladder cancer from urine samples. These genomic tests are designed to assist clinicians in the evaluation of patients presenting with hematuria and in the ongoing surveillance of patients previously diagnosed with the disease. By providing high sensitivity and negative predictive value, the Cxbladder suite helps to accurately rule out urothelial carcinoma, potentially reducing the requirement for invasive clinical procedures such as cystoscopy. The company focuses on integrating its diagnostic tools into standard clinical pathways to improve patient outcomes and healthcare efficiency.

Recent filings

Filing Released Lang Actions
Application for quotation of securities - PEB 5 pages 17.0KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement by Pacific Edge Limited regarding the application for quotation of securities on the ASX. It details the number and type of securities to be quoted, references a previous Appendix 3B announcement about the issue of securities, and provides information about the issued capital following the quotation. The document is an official notice related to the listing or quotation of securities rather than a financial report or earnings release. This type of document corresponds to announcements about share issues or capital changes, specifically the application for quotation of securities after a share issue. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length is 4383 characters, which is consistent with an announcement rather than a full report.
2025-08-12 English
Application for quotation of securities - PEB 5 pages 17.1KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX. It details the number and type of securities to be quoted, the issue date, and references a previous Appendix 3B announcement related to the securities issuance. The document is an official announcement related to capital market activities, specifically the quotation of new securities following a prior issue. It does not contain financial statements or detailed financial performance data, nor is it a report or presentation. It is clearly related to capital/financing activities, specifically the listing of new securities. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is 4585 characters, which is consistent with an announcement rather than a full report.
2025-08-12 English
NZX - Capital Change Notice - Options 3 pages 225.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Capital Change Notice' and details the issuance of options to acquire ordinary shares, including terms such as exercise price, vesting schedule, and authority for the issue. It specifies the number of options issued, the percentage of total shares this represents, and references a board resolution and listing rule. The content focuses on a capital structure change involving options issuance under a long-term incentive plan. There are no financial statements or comprehensive financial data presented, nor is this a report or announcement of a report publication. This fits the definition of a Share Issue/Capital Change announcement, which covers new share issues or capital changes such as options issuance. Therefore, the appropriate classification is SHA (Share Issue/Capital Change). The document length (6568 characters) supports it being a full announcement rather than a brief notice or report publication announcement.
2025-08-12 English
NZX - Capital Change Notice - Shares 3 pages 217.4KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Capital Change Notice' and details the issuance of new shares by Pacific Edge Limited, including the number of shares issued, the pricing, the reasons for issuance, and the authority under which the shares were issued. It includes specifics about placements, share purchase plans, shares issued to directors and employees, and references to NZX Listing Rules. The document is focused on changes to the company's capital structure rather than financial results, management changes, or other report types. It is not a report or announcement of a report publication but a detailed notice of capital changes. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a high confidence in this classification.
2025-08-12 English
Notification regarding unquoted securities - PEB 5 pages 17.4KB
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of unquoted securities under an employee incentive scheme. It includes specifics such as the number of securities issued, issue dates, and mentions key management personnel receiving securities. The document is a formal notification to the ASX about securities issuance, which aligns with announcements regarding share issues or capital changes. There is no financial performance data, management discussion, or audit information. The document is not a report but an announcement of a capital change event. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and detail support a high confidence in this classification.
2025-08-12 English
Application for quotation of securities - PEB 20 pages 546.7KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about securities issued, dates of issue, and references to previous announcements such as Appendix 3B. The document is regulatory in nature, related to the listing and quotation of securities rather than a financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing required by the exchange for securities quotation. Therefore, it fits best under the category of Regulatory Filings (RNS).
2025-08-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.